Jan 27 (Reuters) - Vaxil Bio Ltd VXL.V :
* VAXIL PROVIDES UPDATE ON USAMRIID, ORAL EXPERIMENT AND OTHER GENERAL BUSINESS MATTERS
* VAXIL BIO LTD - MICE RECEIVED THREE SCHEDULED VACCINATIONS BY DECEMBER 31, 2020 AND RESPONDED NORMALLY TO INJECTIONS ADMINISTERED
* VAXIL BIO LTD - MICE HAVE DEVELOPED AN IMMUNE RESPONSE, AS EXPECTED, AND CONSISTENT WITH PREVIOUS IN VIVO (ANIMAL) RESULTS
* VAXIL BIO LTD - EXPECTS TO PROVIDE FURTHER UPDATES IN FIRST HALF OF FEBRUARY 2021
* VAXIL BIO LTD - MEDIATION PROCESS WAS NOT SUCCESSFUL AND COMPANY HAS BEEN NAMED AS A DEFENDANT IN AN ACTION RECENTLY COMMENCED BY ISAAC MARESKY